Aripiprazole-induced tardive dyskinesia: The role of tamoxifen [4]

American Journal of Psychiatry

Volumn 164, Issue 9, 2007, Pages 1436-1437

  Evcimen, Yesne Alici ^a   Evcimen, Harun ^a   Holland, Jimmie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; OLANZAPINE; QUETIAPINE; TAMOXIFEN;

ADULT; ANAMNESIS; BREAST CANCER; CASE REPORT; CLINICAL FEATURE; DRUG DOSE TITRATION; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PRIORITY JOURNAL; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DOPAMINE AGONISTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MIDDLE AGED; PIPERAZINES; QUINOLONES; RECEPTORS, DOPAMINE; TAMOXIFEN;

EID: 34648819692     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07030469     Document Type: Letter

References (7)

1. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, Roth BL, Mailman R: Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuro psychopharmacology 2003; 28:1400-1411
2. Mantal G, Ostacher M, Stern TA: Aripiprazole-related tardive dyskinesia. CNS Spectr 2006; 11:435-439
3. Duggal HS: Aripiprazole-induced improvement in tardive dyskinesia. Can J Psychiatry 2003; 48:771-772
4. Grese TA, Dodge JA: Selective estrogen receptor modulators. Curr Pharm Des 1998; 4:71-92
5. Liu B, Dluzen DE: Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system ovariectomized mice. Neuroendocrinology 2006; 83:295-302
6. Le Saux M, Di Paolo T: Influence of estrogenic compounds on monoamine transporters in rat striatum. Neuroendocrinol 2006; 18:25-32
7. Benarf PJ, Langelier P, Villeneuve A: Estrogens and extrapyramidal system. Lancet 1977; 2:1367-1368